Literature DB >> 779492

Enhancement of tissue invasion in murine aspergillosis by systemic administration of suspensions of killed Corynebacterium parvum.

D M Purnell.   

Abstract

The effect of killed Corynebacterium parvum vaccine on the course of murine aspergillosis is described. A grid-counting technique was employed to quantitate tissue invasion by Aspergillus nidulans in the brain, heart, and kidneys (the target organs) of normal mice and of mice treated systemically with killed C. parvum vaccine. Simultaneous treatment of mice with C. parvum and A. nidulans significantly increased the mortality rate, in contrast to treatment of mice with C. parvum prior to or following A. nidulans, which had no significant effect on mortality. Fungal invasion of the tissues of the brain and kidneys was significantly increased in mice pretreated or posttreated with C. parvum, but fungal invasion of the heart was not effected by these treatements. Simultaneous treatment of mice with C. parvum and A. nidulans significantly increased fungal invasion of the heart but did not effect tissue invasion of the brain and kidneys. It was concluded that killed C. parvum vaccine reduces host resistance to Aspergillus infection and facilitates the curse of fatal murine aspergillosis. These results suggest further caution in applying systemic C. parvum in the therapy of human neoplasia.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 779492      PMCID: PMC2032499     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  13 in total

1.  Effect of Corynebacterium parvum treatment on the growth of Salmonella enteritidis in mice.

Authors:  F M Collins; M T Scott
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

2.  Heterozygous diploid strains of Aspergillus nidulans: enhanced virulence for mice in comparison to a prototrophic haploid strain.

Authors:  D M Purnell; G M Martin
Journal:  Mycopathol Mycol Appl       Date:  1973-04-30

3.  Biological effects of Corynebacterium parvum. IV. Adjuvant and inhibitory activities on B lymphocytes.

Authors:  J G Howard; G H Christie; M T Scott
Journal:  Cell Immunol       Date:  1973-05       Impact factor: 4.868

4.  Biological effects of the adjuvant Corynebacterium parvum. I. Inhibition of PHA, mixed lymphocyte and GVH reactivity.

Authors:  M T Scott
Journal:  Cell Immunol       Date:  1972-11       Impact factor: 4.868

5.  Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.

Authors:  L Milas; J U Gutterman; I Basic; N Hunter; G M Mavligit; E M Hersh; H R Withers
Journal:  Int J Cancer       Date:  1974-10-15       Impact factor: 7.396

6.  Depression of delayed-type hypersensitivity by Corynebacterium parvum: mandatory role of the spleen.

Authors:  M T Scott
Journal:  Cell Immunol       Date:  1974-08       Impact factor: 4.868

7.  Possible immunosuppressive effect of Corynebacterium parvum on infection with Trichinella spiralis.

Authors:  E J Ruitenberg; P A Steerenberg
Journal:  Nat New Biol       Date:  1973-04-04

8.  Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice.

Authors:  N A Sher; S D Chaparas; L E Greenberg; S Bernard
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

9.  Enhancement and depression of the antibody response in mice caused by Corynebacterium parvum.

Authors:  G W Warr; V S Sljivić
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

10.  Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum.

Authors:  J E Swartzberg; J L Krahenbuhl; J S Remington
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

View more
  1 in total

Review 1.  Virulence genetics of Aspergillus nidulans Eidam: a review.

Authors:  D M Purnell
Journal:  Mycopathologia       Date:  1978-12-18       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.